Necesidad de nueva revascularización coronaria en pacientes diabéticos tratados con stents no recubiertos

Pérez P., Luis; Venegas A., Reinaldo; Lecannelier F., Eduardo; Olmos C., Alfonso; Saldaña V., Álvaro; Gajardo, Jorge; Parra, Jessica; Aburto, Grinda; Robles, Isabel; Flores O., Maritza.
Rev. chil. cardiol ; 28(2): 177-183, ago. 2009. tab, graf
Artículo en Español | LILACS | ID: lil-533389

Documentos relacionados

  1. Outcomes of paclitaxel-coated balloon angioplasty for in-stent calcified nodule: An optical coherence tomography study.
  2. How to perform a successful drug-coated balloon angioplasty? Tips and tricks.
  3. Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study.
  4. Procedural and 1-year clinical outcomes of orbital atherectomy for treatment of coronary in-stent restenosis: A single-center, retrospective study.
  5. Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
  6. In-Stent Restenosis Overview: From Intravascular Imaging to Optimal Percutaneous Coronary Intervention Management.
  7. Combined use of intravascular lithotripsy and brachytherapy: A new approach for the treatment of recurrent coronary in-stent restenosis.
  8. Feasibility and safety of orbital atherectomy for the treatment of in-stent restenosis secondary to stent under-expansion.
  9. Northwell intracoronary brachytherapy for the treatment of recurrent drug eluting stent in-stent restenosis (NITDI study group).
  10. A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (ISAR-DESIRE 3A).